Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Cancer Australia"
Count: 129
Selected: 0
NCT02948543Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer
NCT00850772Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer
NCT03091764Evaluation of a Patient-Reported Symptom Index for NMIBC
NCT00096408Laparoscopic Approach to Cancer of the Endometrium
NCT00604994Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
NCT04316013Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial
NCT03464942Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer
NCT04074460Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
NCT05196789Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)
NCT04343885In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
NCT04430192Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
NCT01142011A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia
NCT00098995Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
NCT04720768Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE
NCT05560659Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
NCT05666700CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study
NCT05425862Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT06105411Siderophore-labelled Position Emission Tomography for Correlating Invasive Fungal InfeCtions
NCT05340374Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
NCT05878288Deep sequencIng in Cutaneous Squamous CEll caRciNomas
NCT05383079Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancer
NCT05053854PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
NCT05864742Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma
NCT01755650Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
NCT04769817ProsTIC Registry of Men Treated With PSMA Theranostics
NCT04534725COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;
NCT04914741A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
NCT03874884177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT03331731A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma
NCT02471391ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM)
NCT03363867BEACON - ABC in Recurrent Platinum Resistant HGSOC
NCT02855203Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
NCT05154162PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI
NCT03658447PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)
NCT05570227Metabolic Phenotypes in Melanoma
NCT05222087PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study
NCT05063838Perioperative Pharmacogenomic Testing
NCT03900884Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
NCT04801966Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
NCT05263700FAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown Primary
NCT03299660Avelumab With Chemoradiation in Locally Advanced Rectal Cancer
NCT05024318NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
NCT04985721A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects
NCT03287427MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial
NCT04739670Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer
NCT04234061Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
NCT03980171Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma
NCT05521412EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
NCT02506556Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
NCT03307759Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma